Ramsay Health Care (ASX:RHC): Hospital Growth, Operational Improvement and Portfolio Strategy

Sonal Goyal

09 September 2026 10:47 PM AEST

Ramsay Health Care (ASX:RHC): Hospital Growth, Operational Improvement and Portfolio Strategy

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

• Ramsay is concentrating its strategy on Australian hospitals and UK healthcare operations as it progresses the proposed separation of Ramsay Santé.

• FY26 showed higher underlying earnings, improved cash conversion and better operating performance across all regions.

• Investors are watching whether higher-acuity activity, theatre utilisation and cost discipline can support further Margin improvement.

• The stock was priced at A$53.30 on 9 September 2026.

Ramsay Health Care (ASX:RHC) is one of the better-known private hospital operators in Australia, with additional exposure to the United Kingdom and Europe. Its core Earnings are shaped by hospital admissions, case mix, theatre utilisation, insurer and government funding, labour costs and the productivity of its hospital network. The current Investment story is increasingly about execution: improving returns in Australia, lifting cash generation and simplifying the group structure.

What FY26 showed

For FY26, Ramsay reported underlying EBIT of A$1.16 billion, up 11.5%, while underlying NPAT after non-controlling interests rose 19.3% to A$364.1 million. Australia remained the largest contributor, with underlying EBIT increasing 11.2% to A$639.8 million. Management attributed the improvement to activity growth, higher-acuity work, better theatre utilisation, improved private Health Insurance indexation and cost management.

Australia remains central

The Australian hospital portfolio is the main operational focus. Ramsay is prioritising higher-acuity and selected therapeutic areas including cardiology, orthopaedics and cancer care, while also targeting better capacity utilisation and tighter procurement. Admissions growth of 3.3% and an improvement of roughly 90 basis points in theatre utilisation during FY26 indicate the operational levers management is trying to build on. The Acquisition of National Capital Private Hospital also adds another asset to this domestic strategy.

Simplifying the portfolio

A major strategic issue is the proposed separation of Ramsay Santé. Ramsay has argued that the European Business has a different geographic focus, strategy and capital profile from its core Australian and UK operations. If approved, the separation would simplify the group’s reported financial profile and allow management to concentrate more directly on Australian hospital performance and UK improvement initiatives. Shareholders are due to vote on the proposal in November 2026.

Cash flow and capital discipline

Cash generation has become another important part of the story. Ramsay said all businesses were net cash-flow positive after Capital Expenditure in FY26, while Funding Group Leverage fell below 2 times. The company is also placing greater emphasis on capital discipline, portfolio optimisation and returns on invested capital. These factors matter for a hospital operator because growth projects, technology investment and Facility upgrades can require substantial ongoing expenditure.

Risks investors may monitor

Healthcare funding remains a key sensitivity. Ramsay is exposed to private health insurer indexation, government reimbursement, NHS activity in the UK and Tariff conditions in Europe. Labour costs, Demand variability, regulatory changes and the execution of hospital improvement programs can also influence margins. The proposed Ramsay Santé separation adds transaction and implementation risk until Shareholder approval and completion are secured.

What comes next

For FY27, Ramsay expects Funding Group EBIT growth and margin improvement, with growth targeted in Australia and both UK businesses. Australia is expected to benefit from activity growth, better capacity utilisation and operational initiatives, although the group also plans additional investment in IT, technology and transformation. Investors will therefore be watching whether earnings improvement is matched by continued cash conversion, margin progress and a cleaner portfolio structure.

Conclusion

Ramsay Health Care is entering FY27 with a clearer strategic emphasis on hospital operations, cash generation and portfolio simplification. The Australian business remains the central earnings engine, while UK improvements and the proposed Ramsay Santé separation could reshape the group’s financial profile. The next phase will depend on whether operational gains translate into sustained margin improvement and more efficient capital deployment.

FAQs

Q: What does Ramsay Health Care do?

A:Ramsay operates hospitals and healthcare services, primarily across Australia and the United Kingdom, with European exposure through Ramsay Santé.

Q: What was Ramsay Health Care’s share price on 9 September 2026?

A:The share price was A$53.30.

Q: What is the main strategic change underway?

A:Ramsay is progressing the proposed separation of Ramsay Santé, subject to shareholder approval.

Q: What are investors watching in FY27?

A:Key areas include Australian activity growth, margin improvement, UK performance, cash generation and progress on the Ramsay Santé separation.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.